Cargando…
COVID-19 immune response in hematologic malignancies: analysis of COVID-19 anti-spike antibodies in previously infected and uninfected patients
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883783/ http://dx.doi.org/10.1016/S0002-9629(23)00569-4 |
| _version_ | 1784879580387999744 |
|---|---|
| author | Lanka, SM Niu, A Ramirez, V Gunn, B Foster, S Bratton, M Robinson, J Safah, H Socola, F Huang, Y Zheng, C Elizabeth, N Saba, NS |
| author_facet | Lanka, SM Niu, A Ramirez, V Gunn, B Foster, S Bratton, M Robinson, J Safah, H Socola, F Huang, Y Zheng, C Elizabeth, N Saba, NS |
| author_sort | Lanka, SM |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9883783 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Southern Society for Clinical Investigation. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98837832023-01-30 COVID-19 immune response in hematologic malignancies: analysis of COVID-19 anti-spike antibodies in previously infected and uninfected patients Lanka, SM Niu, A Ramirez, V Gunn, B Foster, S Bratton, M Robinson, J Safah, H Socola, F Huang, Y Zheng, C Elizabeth, N Saba, NS Am J Med Sci Concurrent Session: Hematology and Oncology I Southern Society for Clinical Investigation. Published by Elsevier Inc. 2023-02 2023-01-27 /pmc/articles/PMC9883783/ http://dx.doi.org/10.1016/S0002-9629(23)00569-4 Text en Copyright © 2023 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Concurrent Session: Hematology and Oncology I Lanka, SM Niu, A Ramirez, V Gunn, B Foster, S Bratton, M Robinson, J Safah, H Socola, F Huang, Y Zheng, C Elizabeth, N Saba, NS COVID-19 immune response in hematologic malignancies: analysis of COVID-19 anti-spike antibodies in previously infected and uninfected patients |
| title | COVID-19 immune response in hematologic malignancies: analysis of COVID-19 anti-spike antibodies in previously infected and uninfected patients |
| title_full | COVID-19 immune response in hematologic malignancies: analysis of COVID-19 anti-spike antibodies in previously infected and uninfected patients |
| title_fullStr | COVID-19 immune response in hematologic malignancies: analysis of COVID-19 anti-spike antibodies in previously infected and uninfected patients |
| title_full_unstemmed | COVID-19 immune response in hematologic malignancies: analysis of COVID-19 anti-spike antibodies in previously infected and uninfected patients |
| title_short | COVID-19 immune response in hematologic malignancies: analysis of COVID-19 anti-spike antibodies in previously infected and uninfected patients |
| title_sort | covid-19 immune response in hematologic malignancies: analysis of covid-19 anti-spike antibodies in previously infected and uninfected patients |
| topic | Concurrent Session: Hematology and Oncology I |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883783/ http://dx.doi.org/10.1016/S0002-9629(23)00569-4 |
| work_keys_str_mv | AT lankasm covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT niua covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT ramirezv covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT gunnb covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT fosters covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT brattonm covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT robinsonj covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT safahh covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT socolaf covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT huangy covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT zhengc covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT elizabethn covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients AT sabans covid19immuneresponseinhematologicmalignanciesanalysisofcovid19antispikeantibodiesinpreviouslyinfectedanduninfectedpatients |